6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
5m ago	WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics
6m ago	Pharming Group to report first quarter 2026 financial results and provide business update on May 7
39m ago	Essity: Interim Report Quarter 1, 2026
1h ago	Teck Reports Unaudited First Quarter Results for 2026
1h ago	STMicroelectronics Reports Q1 2026 Financial Results

About

Pharming Group Nv (NASDAQ:PHAR) — investor relations, events, news, and company updates on 6ix.

Latest News

Pharming Group to report first quarter 2026 financial results and provide business update on May 7

Pharming Group announces the 2026 Annual General Meeting of Shareholders

Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older

Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older

Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow

Financials

Revenue

$376.13 M

Market Cap

$1.16 B

P/E Ratio

415.50

EPS

0.04

Community Chat

Ask AI